Welcome to our dedicated page for Fifty 1 Labs news (Ticker: FITY), a resource for investors and traders seeking the latest updates and insights on Fifty 1 Labs stock.
The Fifty 1 Labs, Inc. (OTC: FITY) news page on Stock Titan aggregates company-issued updates and media coverage focused on its AI-enabled health, wellness, and biotechnology activities. Readers can review announcements that describe how the company and its related operations apply artificial intelligence, real-world evidence, and functional medicine concepts to drug repurposing and personalized health solutions.
News items highlight developments involving the company’s operating efforts and its former subsidiary, Fifty1 AI Labs, including AI-driven drug repurposing programs, functional medicine initiatives, and precision medicine projects. Coverage includes details on collaborations with technology and research partners such as BioSpark AI Technologies Inc., ViRx@Stanford under the "BE READI!" initiative, and academic and global health institutions working on areas like sickle cell disease and oncology real-world evidence.
Investors and observers can also find updates on corporate and capital markets steps described by the company, such as engaging a PCAOB-registered auditing firm in connection with a planned uplisting to the OTCQB Venture Market, as well as shareholder communications outlining strategic priorities in biotech and wellness. Clarifications regarding prior collaboration statements, including those related to LUNR Aerospace, are part of the news record and provide additional context on the company’s relationships.
By following this news feed, users can see how Fifty 1 Labs presents its AI-focused research, partnerships, and strategic plans over time, with information directly sourced from its press releases and related announcements.
4Cable TV International (CATV) has announced several strategic developments on March 20, 2025. The company facilitated the acquisition of Genetic Networks by Fifty 1 Labs, Inc. (FITY), which will result in a dividend distribution to CATV shareholders pending FINRA approval.
The company has significantly strengthened its financial position by eliminating $800,000 in debt and reducing 930 million dilutive shares, following a previous reduction of 7.8 billion shares on March 17, 2025. This brings the total share reduction to 8.7 billion shares.
Current Interim CEO Michael Feldenkrais will resign but oversee the transition as the company prepares for a reverse merger with a new company. The merger, expected in the coming weeks, will include a new name, ticker symbol, and management team.
Fifty 1 Labs (OTCPK: FITY), formerly Consumer Automotive Finance (OTCPK: CAFI), has completed its name and ticker symbol change with FINRA, now trading as FITY on the OTC market. The company, operating in the sports supplement, fitness equipment, and health and wellness sectors, has submitted responses to a second round of comments in its effort to regain SEC Rule 15c2-11 compliance.
The company has rescheduled its teleconference to March 17th, 2025, where management will discuss strategic direction and provide updates. CEO Brandon Spikes emphasized the importance of the name change in strengthening their market position and highlighted that regaining 15c2-11 compliance remains a priority for improving shareholder transparency and liquidity.